An Exploration of Ranibizumab Injection Frequency in Patients with Diabetic Macular Edema: A Post-hoc Analysis of the Restore and Retain Study

被引：0
|
作者：
Figueira, Joao [1 ]
Margaron, Philippe [2 ]
Hashmonay, Ron [2 ]
机构：
[1] AIBILI, Coimbra, Portugal
[2] Novartis Pharma AG, Basel, Switzerland
来源：
OPHTHALMOLOGICA | 2014年 / 232卷
关键词：
Diabetic Macular Edema; Ranibizumab; RESTORE Study; RETAIN Study; Visual Acuity;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
160
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [41] Safety Profile of Diabetic Macular Edema Patients Treated Over 12 Months With Ranibizumab in the RESOLVE Study
    Garcia-Arumi, J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [42] 36-month safety and efficacy of ranibizumab in diabetic macular oedema: the RESTORE extension study (final analysis)
    Boixadera, A.
    Garcia-Arumi, J.
    DIABETOLOGIA, 2013, 56 : S28 - S29
  • [43] Baseline predictors of 3-year responses to ranibizumab and laser photocoagulation therapy in patients with visual impairment due to diabetic macular edema (DME): the RESTORE study
    Mitchell, Paul
    Chong, Victor
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [44] Correlation of Change in Macular Thickness With Change in Visual Acuity in Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials
    Nanegrungsunk, Onnisa
    Gu, Sophie Z.
    Bressler, Susan B.
    Du, Weiming
    Amer, Fouad
    Moini, Hadi
    Bressler, Neil M.
    JOURNAL OF VITREORETINAL DISEASES, 2022, 6 (04) : 284 - 289
  • [45] Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema Report From RESTORE, RIDE, and RISE Trials
    Bressler, Neil M.
    Varma, Rohit
    Mitchell, Paul
    Suner, Ivan J.
    Dolan, Chantal
    Ward, James
    Ferreira, Alberto
    Ehrlich, Jason S.
    Turpcu, Adam
    JAMA OPHTHALMOLOGY, 2016, 134 (02) : 160 - 166
  • [46] Sustained Diabetic Retinopathy Severity Improvement with Intravitreal Aflibercept in Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials
    Dhoot, Dilsher Singh
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [47] The REVEAL Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema
    Ishibashi, Tatsuro
    Li, Xiaoxin
    Koh, Adrian
    Lai, Timothy Y. Y.
    Lee, Fenq-Lih
    Lee, Won-Ki
    Ma, Zhizhong
    Ohji, Masahito
    Tan, Nikolle
    Cha, Sung Bok
    Shamsazar, Jila
    Yau, C. Lillian
    OPHTHALMOLOGY, 2015, 122 (07) : 1402 - 1415
  • [48] Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)
    Van Aken, Elisabeth
    Favreau, Meredis
    Ramboer, Eva
    Denhaerynck, Kris
    MacDonald, Karen
    Abraham, Ivo
    Brie, Heidi
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 4173 - 4185
  • [49] Long-term safety and efficacy of ranibizumab 0.5 mg in patients with diabetic macular oedema of the RESTORE extension study
    Lang, G. E.
    DIABETOLOGIA, 2012, 55 : S85 - S85
  • [50] Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)
    Schauwvlieghe, A. M. E.
    Dijkman, G.
    Hooymans, J. M.
    Verbraak, F. D.
    Hoyng, C. B.
    Dijkgraaf, M. G. W.
    Van Leeuwen, R.
    Vingerling, J. R.
    Moll, A. C.
    Schlingemann, Reinier O.
    BMC OPHTHALMOLOGY, 2015, 15
12345